Capital Advisors Ltd’s Guardant Health GH Stock Holding History

Capital Advisors Ltd’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	8	–	–	﹤0.01%	1233
2026 Q1	$1K	Hold	8	–	–	﹤0.01%	1220
2025 Q4	$1K	Hold	8	–	–	﹤0.01%	1199
2025 Q3	$1K	Hold	8	–	–	﹤0.01%	1197
2025 Q2	$0	Hold	8	–	–	﹤0.01%	1446
2025 Q1	$0	Hold	8	–	–	﹤0.01%	1430
2024 Q4	$0	Hold	8	–	–	﹤0.01%	1456
2024 Q3	$0	Hold	8	–	–	﹤0.01%	1469
2024 Q2	$0	Buy	+8	New	+$186	﹤0.01%	1486
2022 Q4	–	Sell	-40	Closed	-$2K	–	1366
2022 Q3	$2K	Buy	+40	New	+$2.05K	﹤0.01%	854
2022 Q1	–	Sell	-1	Closed	–	–	1018
2021 Q4	$0	Buy	+1	New	+$103	﹤0.01%	862

Other funds holding GH

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

MAG

MRA Advisory Group Parsippany, New Jersey $276M AUM 31.26% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Capital Advisors Ltd's GH Position: Q2 2026 in Review

Capital Advisors Ltd held its Guardant Health (GH) position steady in Q2 2026 at 8 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Capital Advisors Ltd first reported a position in GH in Q4 2021 and has held it in 11 quarters since. The position peaked at $2K in Q3 2022. 46 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Capital Advisors Ltd held 8 shares of Guardant Health worth $1K as of Q2 2026.
Capital Advisors Ltd left its Guardant Health share count unchanged in Q2 2026.
Guardant Health made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1233 holding.
Capital Advisors Ltd first reported a position in Guardant Health in Q4 2021 and has held it in 11 quarters since.
Capital Advisors Ltd's Guardant Health position peaked at $2K in Q3 2022.
46 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.